Novo Nordisk
Novo Nordisk – Global Leader in Diabetes and Obesity Care
They lead the healthcare industry in diabetes and obesity treatment. The company also develops therapies for hemophilia and growth disorders. With over 95 years of experience, Novo Nordisk creates innovative medications and devices that improve patient outcomes. The company operates in more than 80 countries and delivers life-changing healthcare solutions. it focuses on sustainability, research, and patient-centered care.
Showing all 3 results
-
CagriReta
£210.00 -
Ozempic
Price range: £99.00 through £304.00Select options This product has multiple variants. The options may be chosen on the product page -
Wegovy
Price range: £99.00 through £329.00Select options This product has multiple variants. The options may be chosen on the product page